Jan 30, 2025 · The vaccine only contains a gene from the Ebola virus, not the whole virus. Recombinant vaccines, like ERVEBO®, act like a natural infection, so they're especially good at teaching the immune system how to fight germs.

Jan 11, 2020 · The Strategic Advisory Group of Experts (SAGE) on Immunization is reviewing the emerging clinical data from the people vaccinated since 2015 to determine how long the vaccine protects a person from Ebola virus infection. A recommendation for preventive use …

Ebola vaccines are vaccines either approved or in development to prevent Ebola. As of 2022, there are only vaccines against the Zaire ebolavirus . The first vaccine to be approved in the United States was rVSV-ZEBOV in December 2019.

Jan 31, 2025 · Ebola vaccine is a live virus vaccine that is administered as a single dose by injection into a muscle. The vaccine contains a weakened strain of the vesicular stomatitis virus that has been altered to contain a gene from the Ebola virus.

The U.S. Food and Drug Administration announced today the approval of Ervebo, the first FDA-approved vaccine for the prevention of Ebola virus disease (EVD), caused by Zaire ebolavirus in...

Apr 20, 2023 · Vaccines to protect against some types of Ebola have been used to control the spread of Ebola in outbreaks. Other vaccines are in development. Early supportive care with rehydration and the treatment of symptoms improves survival.

ERVEBO can be given as pre-exposure vaccination for adults aged ≥18 years who fall into one of the three occupational categories: Outbreak responders who will be traveling to an area with an active outbreak of Ebola virus (species orthoebolavirus zairense).

Currently there are no licensed vaccines to prevent Ebola virus disease. However, multiple investigational Ebola vaccines have been tested in numerous clinical trials around the world. NIAID has supported the development of various candidates, including the rVSV-ZEBOV vaccine developed by Merck.

Jan 24, 2020 · Vaccines based on the Ad26 platform administered to >8000 participants had an acceptable safety profile and induced potent humoral and cellular immune responses.

Jul 1, 2020 · In response to a new Ebola outbreak in Guinea, Johnson & Johnson is providing up to 200,000 doses of its Ebola vaccine regimen to the country for a World Health Organization supported clinical trial. Learn more about the initiative and other top facts about the vaccine regimen for the deadly virus.